Lipoxygenase (LOX) signaling in epilepsy: Pathophysiology and therapeutic prospects

Md. Asaduzzaman Rakib, Ying Yu, Jianxiong Jiang · 2026

Read Lipoxygenase (LOX) signaling in epilepsy: Pathophysiology and therapeutic prospects by Md. Asaduzzaman Rakib, Ying Yu, Jianxiong Jiang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13410618.txt.

Description

Md. Asaduzzaman Rakib, Ying Yu, and Jianxiong Jiang review in 2026 a family of fat-processing enzymes as fresh targets for epilepsy drugs. About one person in fifty lives with epilepsy, and near a third keep having seizures despite current medicines. Brain inflammation after injury is now seen as a key spark for those seizures.

The enzymes, called lipoxygenases, turn a common fatty acid into signals that drive swelling, oxidative stress, and cell death in brain tissue. Two branches, 5-LOX and the 12/15-LOX pair, stand out in seizure biology and in linked mood problems. Blocking them calmed seizures in early animal work. The review weighs that evidence and sets out what safer, sharper blockers would need to prove.

Catalog record

CREATORMd. Asaduzzaman Rakib, Ying Yu, Jianxiong Jiang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE51576
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13410618

Browse the full library · About the Tower of Babel